CPA-7

CAS No. 16961-77-6

CPA-7( CPA 7 | CPA7 )

Catalog No. M12586 CAS No. 16961-77-6

A platinum-containing compound that disrupts STAT3 signaling, inhibits cell growth and induces apoptosis in STAT3-activated cancer cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CPA-7
  • Note
    Research use only, not for human use.
  • Brief Description
    A platinum-containing compound that disrupts STAT3 signaling, inhibits cell growth and induces apoptosis in STAT3-activated cancer cells.
  • Description
    A platinum-containing compound that disrupts STAT3 signaling, inhibits cell growth and induces apoptosis in STAT3-activated cancer cells; selectively and significantly inhibits Stat3 activation and DNA-binding activity, induces regression of colon tumors in mouse model at 5mg/kg, with the abrogation of persistent Stat3 activity in tumors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CPA 7 | CPA7
  • Pathway
    JAK/STAT Signaling
  • Target
    STAT
  • Recptor
    STAT
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    16961-77-6
  • Formula Weight
    381.501
  • Molecular Formula
    Cl3H6N3O2Pt
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    Platinum, diamminetrichloronitro- (8CI)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Turkson J, et al. Mol Cancer Ther. 2004 Dec;3(12):1533-42. 2. Assi HH, et al. J Pharmacol Exp Ther. 2014 Jun;349(3):458-69. 3. Littlefield SL, et al. Inorg Chem. 2008 Apr 7;47(7):2798-804. 4. Liang M, et al. BMC Cancer. 2016 Jul 19;16:504.
molnova catalog
related products
  • STA-21

    A small-molecule inhibitor of STAT3; inhibits Stat3 DNA binding activity, Stat3 dimerization, and Stat3-dependent luciferase activity (20-30 uM).

  • NT219

    NT219 is a dual inhibitor of insulin receptor substrate 1/2 (IRS1/2) and STAT3, enhances the aggregation of misfolded prion protein NT219 affects the levels of certain molecular chaperones and inhibits STAT3 phosphorylation NT219 is useful for the study of cancer and neurodegenerative diseases.

  • SD-1029

    SD-1029 (NSC 371488) is a potent inhibitor of Stat3 activation.